Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $2.56 billion. The enterprise value is $1.82 billion.

Market Cap	2.56B
Enterprise Value	1.82B

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

APGE has 56.90 million shares outstanding. The number of shares has increased by 272.26% in one year.

Current Share Class	43.42M
Shares Outstanding	56.90M
Shares Change (YoY)	+272.26%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	2.08%
Owned by Institutions (%)	80.80%
Float	27.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.49
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.39, with a Debt / Equity ratio of 0.02.

Current Ratio	16.39
Quick Ratio	16.28
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.65% and return on invested capital (ROIC) is -19.27%.

Return on Equity (ROE)	-25.65%
Return on Assets (ROA)	-18.51%
Return on Capital (ROIC)	-19.27%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +146.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+146.12%
50-Day Moving Average	54.57
200-Day Moving Average	49.89
Relative Strength Index (RSI)	33.54
Average Volume (20 Days)	392,767

Short Selling Information

The latest short interest is 6.81 million, so 11.97% of the outstanding shares have been sold short.

Short Interest	6.81M
Short Previous Month	6.87M
Short % of Shares Out	11.97%
Short % of Float	24.77%
Short Ratio (days to cover)	20.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-178.14M
Pretax Income	-103.55M
Net Income	-146.66M
EBITDA	n/a
EBIT	-178.14M
Earnings Per Share (EPS)	-$2.77

Full Income Statement

Balance Sheet

The company has $526.05 million in cash and $12.14 million in debt, giving a net cash position of $741.66 million or $13.03 per share.

Cash & Cash Equivalents	526.05M
Total Debt	12.14M
Net Cash	741.66M
Net Cash Per Share	$13.03
Equity (Book Value)	734.40M
Book Value Per Share	12.91
Working Capital	501.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$133.21 million and capital expenditures -$1.32 million, giving a free cash flow of -$134.53 million.

Operating Cash Flow	-133.21M
Capital Expenditures	-1.32M
Free Cash Flow	-134.53M
FCF Per Share	-$2.36

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-272.26%
Shareholder Yield	-272.26%
Earnings Yield	-5.72%
FCF Yield	-5.25%

Analyst Forecast

The average price target for APGE is $75.20, which is 66.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$75.20
Price Target Difference	66.96%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	1.91%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1